CD4 and Hodgkins lymphoma: This is in line with studies by the French Hospital Database on HIV and Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), strengthening the potential of the CD4+ T cell count as a surrogate marker to identify HIV+ patients with a high risk to develop HL [17, 76–78].